LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element.

Published in:

1996

By:

• Birch, Kimberly A.;
• Heath, William F.;
• Hermeling, Ronald N.;
• Johnston, Cecile M.;
• Stramm, Larry;
• Dell, Colin;
• Smith, Colin;
• Williamson, Joseph R.;
• Reifel-Miller, Anne;
• Birch, K A;
• Heath, W F;
• Hermeling, R N;
• Johnston, C M;
• Stramm, L;
• Dell, C;
• Smith, C;
• Williamson, J R;
• Reifel-Miller, A

Publication type:

journal article